Michael D Peake
Overview
Explore the profile of Michael D Peake including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
937
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abiodun A, Ju C, Welch C, Lai J, Tyrer F, Chambers P, et al.
BMJ Oncol
. 2025 Jan;
3(1):e000323.
PMID: 39886129
Objective: Fluoropyrimidine chemotherapy is a first-line treatment for many gastrointestinal (GI) cancers, however, cardiotoxicity concerns may limit administration in patients with pre-existing cardiovascular disease (CVD). This study investigated the association...
2.
Onifade A, Quaife S, Holden D, Chung D, Birchall M, Peake M, et al.
BMC Health Serv Res
. 2024 Nov;
24(1):1481.
PMID: 39605052
Introduction: Cancer multi-disciplinary team meetings (MDTM) assemble clinical experts to make diagnostic and treatment recommendations. MDTMs can take place in person, virtually, or in a hybrid format. Virtual and hybrid...
3.
McInnerney D, Quaife S, Cooke S, Mitchinson L, Pogson Z, Ricketts W, et al.
BMC Cancer
. 2024 Aug;
24(1):942.
PMID: 39095781
Background: Lung cancer is the third most common cancer in the UK and the leading cause of cancer mortality globally. NHS England guidance for optimum lung cancer care recommends management...
4.
Ali N, Nelson D, McInnerney D, Quaife S, Laparidou D, Selby P, et al.
Support Care Cancer
. 2024 Feb;
32(3):144.
PMID: 38316704
Purpose: To synthesize the qualitative literature exploring the experiences of people living with lung cancer in rural areas. Methods: Searches were performed in MEDLINE, CINAHL, and PsycINFO. Articles were screened...
5.
Teece L, Sweeting M, Hall M, Coles B, Oliver-Williams C, Welch C, et al.
Circ Cardiovasc Qual Outcomes
. 2023 Jun;
16(6):e009236.
PMID: 37339190
Background: An increasing proportion of patients with cancer experience acute myocardial infarction (AMI). We investigated differences in quality of AMI care and survival between patients with and without previous cancer...
6.
McInnerney D, Chung D, Mughal M, Onifade A, Holden D, Goodman J, et al.
BMJ Open
. 2023 Apr;
13(4):e064911.
PMID: 37076166
Introduction: In the UK, the National Cancer Plan (2000) requires every cancer patient's care to be reviewed by a multidisciplinary team (MDT). Since the introduction of these guidelines, MDTs have...
7.
Coles B, Welch C, Motiwale R, Teece L, Oliver-Williams C, Weston C, et al.
Eur Heart J Acute Cardiovasc Care
. 2023 Mar;
12(5):315-327.
PMID: 36888552
Aims: Currently, little evidence exists on survival and quality of care in cancer patients presenting with acute heart failure (HF). The aim of the study is to investigate the presentation...
8.
Gosney J, Peake M, Kerr K
J Clin Pathol
. 2023 Jan;
77(2):135-139.
PMID: 36604178
Aims: Programmed cell death ligand 1 (PD-L1) expression, used universally to predict response of non-small cell lung cancer (NSCLC) to immune-modulating drugs, is a fragile biomarker due to biological heterogeneity...
9.
Battisti N, Welch C, Sweeting M, de Belder M, Deanfield J, Weston C, et al.
JACC CardioOncol
. 2022 Jul;
4(2):238-253.
PMID: 35818547
Background: Although a common challenge for patients and clinicians, there is little population-level evidence on the prevalence of cardiovascular disease (CVD) in individuals diagnosed with potentially curable cancer. Objectives: We...
10.
Hall H, Tocock A, Burdett S, Fisher D, Ricketts W, Robson J, et al.
Thorax
. 2021 Aug;
77(8):762-768.
PMID: 34404753
Background: National targets for timely diagnosis and management of a potential cancer are driven in part by the perceived risk of disease progression during avoidable delays. However, it is unclear...